ZECHARIA LIND: Open Payments
NPI 1306894324 · LAKEWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,760 in 130 payments from 15 companies in 2025. Trend: 2023 $1,369 · 2024 $2,908 · 2025 $1,760
Food & beverage: $1,688Education: $72
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 36 | $382 |
| Incyte Corporation | 19 | $270 |
| PFIZER INC. | 20 | $229 |
| LEO Pharma Inc. | 12 | $175 |
| ABBVIE INC. | 13 | $169 |
| Janssen Biotech, Inc. | 7 | $110 |
| Organon LLC | 6 | $78 |
| GENZYME CORPORATION | 4 | $76 |
| SANOFI-AVENTIS U.S. LLC | 1 | $72 |
| Galderma Laboratories, L.P. | 4 | $63 |
Products named: OPZELURA, COSENTYX, CIBINQO, DUPIXENT, ADBRY, Rhapsido, TREMFYA, RINVOQ.
Industry payments across NJ — which companies pay providers there.
